Insiders · INDV

Ryan Preblick

Chief Financial Officer at Indivior Pharmaceuticals, Inc. (INDV) since January 2026

Ryan Preblick has filed 5 insider reports with the SEC since January 2026, as chief Financial Officer at Indivior Pharmaceuticals, Inc. (INDV). In the last 12 months Ryan Preblick sold $1.36M of stock on the open market. In the latest filing, on June 10, 2026, Ryan Preblick sold 36,000 shares of Indivior Pharmaceuticals, Inc. (INDV) for $1.36M at an average of $37.70.

Filings
5
Companies
1
Bought on market
None
Sold on market
$1.36M

Companies where Ryan Preblick is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Indivior Pharmaceuticals, Inc. logo
INDV
Indivior Pharmaceuticals, Inc.
Chief Financial Officersince January 2026284,751$1.36M$36.28Jun 10, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Ryan Preblick with

Other insiders at the same companies

Questions about Ryan Preblick

What is Ryan Preblick's role at Indivior Pharmaceuticals, Inc.?
Ryan Preblick reports to the SEC as chief Financial Officer at Indivior Pharmaceuticals, Inc. (INDV), according to the latest filing on June 10, 2026.
How many shares does Ryan Preblick own?
After the latest filing that states it, Ryan Preblick directly owned 284,751 shares of Indivior Pharmaceuticals, Inc. (INDV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Ryan Preblick bought or sold stock recently?
The most recent open-market sale was on June 8, 2026: sold 36,000 shares of Indivior Pharmaceuticals, Inc. (INDV) for $1.36M at an average of $37.70.
How do I get alerts when Ryan Preblick files?
Follow Ryan Preblick on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ryan Preblick (SEC CIK 0002014866). Totals count each trade once, skipping amendments whose original is on file, from Jan 7, 2026 on. View on SEC EDGAR